Stock Price Forecast

April 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Akoya Biosciences, Inc. chart...

About the Company

We do not have any company description for Akoya Biosciences, Inc. at the moment.

Exchange

Nasdaq

$96M

Total Revenue

348

Employees

$197M

Market Capitalization

-2.30

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AKYA News

AKYA Akoya Biosciences, Inc.

27d ago, source: Seeking Alpha

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific ...

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript

1mon ago, source: Insider Monkey

Akoya Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.27. AKYA isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)

9d ago, source:

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Akoya Biosciences (AKYA – Research Report), ...

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

1mon ago, source: Nasdaq

March 04, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ...

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

13d ago, source:

Akoya Biosciences will demonstrate new uses of its PhenoCode Signature Panels for accelerating discovery and validation of spatial biomarkers using the PhenoImager HT 2.0 platform. The company will ...

Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?

2mon ago, source: Zacks.com on MSN

stocks here >>>> Akoya is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Avidity Biosciences, Inc. (RNA), finished the last trading session ...

Akoya: Q4 Earnings Snapshot

1mon ago, source: Times Union

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $10.8 million in its fourth quarter. The Marlborough, Massachusetts-based company ...

Akoya Biosciences Inc AKYA

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Akoya Biosciences Inc AKYA

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AKYA Akoya Biosciences, Inc.

24d ago, source: Seeking Alpha

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Akoya Biosciences Inc (AKYA)

1mon ago, source: Investing

Akoya Biosciences, Inc. is a life sciences technology company. The Company delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...